Validation of albumin platelet product as a non-invasive fibrosis staging tool in patients with chronic HCV-related liver disease
Abstract Background and aim: The Albumin Platelet Product (APP) has emerged as a promising non-invasive biomarker for fibrosis staging in chronic liver disease (CLD). This cross-sectional study aims to evaluate the effectiveness of APP compared to established non-invasive markers of fibrosis in an E...
Saved in:
Main Authors: | Maha Elsabaawy, Mohamed Eissa, Ahmed Shaban, Madiha Naguib |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-06-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-07456-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
by: I. A. Goncharova, et al.
Published: (2023-03-01) -
Non-invasive of liver fibrosis diagnostics: the role of serum markers
by: A. F. Sheptulina, et al.
Published: (2015-05-01) -
The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01) -
IMMUNE PREDICTORS OF FIBROGENESIS AND THEIR APPLICATION FOR NON-INVASIVE DIAGNOSTICS OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
by: M. V. Shipunov, et al.
Published: (2012-05-01) -
A PREDICTIVE MODEL FOR NON-INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS VIRUS INFECTION
by: A. A. Ostanin, et al.
Published: (2014-07-01)